Exploring a new therapy for adolescents with PTSD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the clinical and biomolecular characteristics of Reminder Focused Positive Psychiatry (RFPP) in adolescents aged 11-15 years who have been diagnosed with posttraumatic stress disorder (PTSD). The research will involve recruiting 60 eligible adolescents from the Olive View UCLA Pediatrics Clinics, where they will be randomized into either the RFPP intervention group or an attentional control condition. The aim is to assess the feasibility and effectiveness of RFPP in improving PTSD symptoms and vascular function. Parental consent and adolescent assent will be obtained prior to participation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Boy/Girl with documented PTSD,
* aged 11- 15 years old,
* able to read/write in English

Exclusion Criteria:

* presence of intellectual disabilities,
* presence of psychotic or self-injurious behavior,
* presence of seizure disorder,
* presence of language disorder,
* presence of eye disorders,
* presence of other neurodevelopmental disorders,
* presence of diagnosis of substance use disorder.

Where it's running

• UCLA
  Los Angeles, California, United States Recruiting

Study contacts

• Study coordinator: Naser Ahmadi, MD PhD
• Email: ahmadi@ucla.edu
• Phone: 424 298 8846

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD

  This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.

  Recruiting Phase 2 University of Haifa · Haifa · NCT07771530

• Self-Help CPT with WoVeN Peer Support for Women Veterans with PTSD

  This study tests a self-help Cognitive Processing Therapy and a WoVeN peer-support program, alone and together, to see if they improve PTSD symptoms and well-being for women veterans.

  Recruiting Boston University · Boston, Massachusetts · NCT07250061

• Adaptive, personalized PTSD care for veterans

  This program will try different therapy sequences plus optional text-message homework reminders to see if switching treatments or sending prompts helps veterans with PTSD who aren't improving or are missing between-session homework.

  Recruiting at 3 sites The University of Texas Health Science Center at San Antonio · Augusta, Georgia and 3 other locations · NCT07176273

• Multi‑Mode Cognitive Processing Therapy for adults with PTSD

  This program will try a multi‑mode form of Cognitive Processing Therapy to reduce PTSD symptoms and improve sleep and mood in adults aged 20–65 with PTSD.

  Recruiting Far Eastern Memorial Hospital · New Taipei City, Banqiao District · NCT07105345

• Improving thinking, daily functioning, mood, and sleep after mild traumatic brain injury and PTSD

  This project will test whether adding morning bright light therapy to compensatory cognitive training helps post-9/11 Veterans with mild traumatic brain injury and PTSD think, function, and sleep better compared with a neutral ion generator.

  Recruiting at 2 sites VA Office of Research and Development · San Diego, California and 1 other locations · NCT07055633

• Combined MDMA and psilocybin treatment for Veterans with PTSD

  This trial tests whether giving MDMA followed 30 minutes later by psilocybin can be safely used to reduce symptoms in military veterans with long-standing PTSD.

  Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT06989957

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.